Corcept Therapeutics (CORT) leverages Korlym’s commercial success in hypercortisolism, generating $559.3M in nine-month 2025 ...

Across decades of warfare, only a handful of weapons earned the kind of trust that keeps them in service long after their ...

The Roundhill Generative AI & Technology ETF (NYSEARCA:CHAT) soared just over 45% in 2025, outpacing the S&P 500’s 17% gain ...

Vericel's future hinges on scaling MACI, as Epicel and Nexobrid have stalled and face capped demand in niche markets. Read ...

The decentralized finance sector is witnessing a pivotal shift, where investors increasingly prioritize projects with ...

The branch has applied to extend opening hours by six hours every day, but objections have been raised over noise and child ...